Pulmonary tuberculosis

肺结核
  • 文章类型: Case Reports
    尽管通常是可以治疗和预防的,肺结核(PTB)是导致死亡的最常见感染因子之一。结核病的误诊经常导致不必要的诊断程序并推迟治疗的开始。
    肺结核(PTB)可以表现出各种异常的放射学和临床特征。结核病的误诊经常导致不必要的诊断程序并推迟治疗的开始。这里,我们描述了一名50岁的男性,他的放射学发现和非典型症状表现为癌性病变,导致最初诊断为肺癌.然而,肺病变的组织病理学和活检显示慢性肉芽肿性炎症伴干酪样坏死,确认PTB是真正的原因,没有进一步的恶性肿瘤指征。
    UNASSIGNED: Despite being generally treatable and preventative, pulmonary tuberculosis (PTB) is one of the most common infectious agents that cause death. Misdiagnosis of TB frequently leads to unwarranted diagnostic procedures and postpones the start of treatment.
    UNASSIGNED: Pulmonary tuberculosis (PTB) can present with various unusual radiological and clinical characteristics. Misdiagnosis of TB frequently leads to unwarranted diagnostic procedures and postpones the start of treatment. Here, we describe a 50-year-old man who presented with a cancerous-type lesion on radiological findings and atypical symptoms that led to an initial diagnosis of lung cancer. However, histopathology and biopsy of the lung lesion revealed chronic granulomatous inflammation with caseous necrosis, confirming PTB as the true cause, with no further indications of malignancy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    引言肺结核(TB)仍然是全球健康问题,结核分枝杆菌广泛耐药(XDR)菌株的出现加剧了这种情况。本研究采用先进的分子技术,特别是聚合酶链反应(PCR)分析,全面表征诊断为肺结核患者XDR病原菌的遗传格局。该研究的目的是通过应用PCR阐明与肺结核菌株耐药性相关的基因,并分析有助于对多种药物产生耐药性的特定遗传基因座。材料和方法从Saveetha医学院和医院的三级医疗机构收集了总共116例疑似结核病的临床样本,以鉴定MTB。其中包括痰(n=35),鼻拭子(n=17),血液(n=44),支气管肺泡灌洗(BAL)(n=20)。处理收集的样本并进行DNA提取。根据协议,进行DNA沉淀的重建。将重构的DNA储存在-20°C用于PCR测定。从获得的阳性样本样本中,XDR肺结核标本集中于靶向基因,特别是利福平抗性的rpoB基因,inhA,和katG基因为异烟肼抗性的启动子区。结果在总共获得的116个样本中,53例肺结核检测呈阳性,指示分枝杆菌感染。在这些积极的案例中,43名患者在三级医疗机构接受了治疗。随后,用提取的目标基因rpoB的DNA进行PCR测定,inhA,还有KatG.具体来说,22个痰样本显示rpoB基因表达,inhA,还有KatG,而9个鼻拭子显示rpoB和inhA基因的表达。此外,在7份血液标本中检测到rpoB基因表达,rpoB和inhA基因在五个BAL样品中均表达。结论采用先进和快速的分子检测和口服给药方案可以促进XDR-TB的快速诊断和有效治疗。利用新开发和重新利用的抗结核药物,如pretomanid,bedaquiline,利奈唑胺,和乙二甲酰胺.坚持这些建议有望有效管理广泛耐药结核病。然而,进行精心设计的临床试验和研究,以进一步评估新药和较短的治疗方案的疗效,从而确保持续改进这一具有挑战性的条件的管理。
    Introduction Pulmonary tuberculosis (TB) remains a global health concern, exacerbated by the emergence of extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis. This study employs advanced molecular techniques, specifically polymerase chain reaction (PCR) profiling, to comprehensively characterize the genetic landscape of XDR pathogenic bacteria in patients diagnosed with pulmonary TB. The objective of the study is to elucidate the genes that are associated with drug resistance in pulmonary TB strains through the application of PCR and analyze specific genetic loci that contribute to the development of resistance against multiple drugs. Materials and methods A total of 116 clinical samples suspected of TB were collected from the tertiary healthcare setting of Saveetha Medical College and Hospitals for the identification of MTB, which includes sputum (n = 35), nasal swabs (n = 17), blood (n = 44), and bronchoalveolar lavage (BAL) (n = 20). The collected specimens were processed and subjected to DNA extraction. As per the protocol, reconstitution of the DNA pellet was carried out. The reconstituted DNA was stored at -20 °C for the PCR assay. From the obtained positive sample specimens, XDR pulmonary TB specimens were focused on the targeted genes, specifically the rpoB gene for rifampicin resistance, inhA, and katG gene for thepromoter region for isoniazid resistance. Results Out of a total of 116 samples obtained, 53 tested positive for pulmonary TB, indicative of a mycobacterial infection. Among these positive cases, 43 patients underwent treatment at a tertiary healthcare facility. Subsequently, a PCR assay was performed with the extracted DNA for the target genes rpoB, inhA, and katG. Specifically, 22 sputum samples exhibited gene expression for rpoB, inhA, and katG, while nine nasal swabs showed expression of the rpoB and inhA genes. Additionally, rpoB gene expression was detected in seven blood specimens, and both rpoB and inhA genes were expressed in five BAL samples. Conclusion The swift diagnosis and efficient treatment of XDR-TB can be facilitated by employing advanced and rapid molecular tests and oral medication regimens. Utilizing both newly developed and repurposed anti-TB drugs like pretomanid, bedaquiline, linezolid, and ethionamide. Adhering to these current recommendations holds promise for managing XDR-TB effectively. Nevertheless, it is significant to conduct well-designed clinical trials and studies to further evaluate the efficacy of new agents and shorter treatment regimens, thus ensuring continuous improvement in the management of this challenging condition.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    结核病(TB)诊断的延迟在个人和社区水平上都是一个重大问题。结核病的延迟诊断会导致更严重的疾病表现。死亡风险更高,以及社区中更高的疾病传播。我们进行了这项研究,以评估延迟诊断肺结核的程度和相关原因。
    这项研究是在结核病和呼吸系统疾病科进行的,J.N.医学院,Aligarh,从2020年6月到2022年5月。共2053例新肺结核患者,他首先咨询了任何私人医疗保健提供者(HCP)进行治疗,参加了这项研究。使用预先设计的问卷通过访谈技术收集所需的信息。
    共2053名患者纳入研究。94%的患者出现症状后,肺结核的诊断明显延迟2周以上。延迟的程度为8天至240天,平均为36.33天。患者就诊HCP的延迟并不明显。只有5.85%的患者在出现症状后寻求任何医疗保健的明显延迟超过2周。HCP的延迟占总延迟的很大一部分,平均为31.77天。HCP拖延的主要原因是没有调查结核病。医院延误并不严重。平均住院时间为5.82天。
    印度结核病诊断的延迟非常高。HCP的延迟占总延迟的较大部分。信息,教育和传播(IEC)活动将在减少延误方面发挥重要作用。根据国家结核病消除计划(NTEP)指南,所有HCP应积极参与尽早对嫌疑人进行结核病诊断。
    UNASSIGNED: Delay in the diagnosis of tuberculosis (TB) is a significant problem at both individual and community levels. Delayed diagnosis of TB contributes to more severe disease manifestations, higher risk of death, and higher disease transmission in the community. We conducted this study to assess the extent and associated reasons for delay in diagnosis of pulmonary TB.
    UNASSIGNED: This study was conducted in the Department of TB and Respiratory Diseases, J. N. Medical College, Aligarh, from June 2020 to May 2022. A total of 2053 new pulmonary TB patients, who first consulted any private healthcare provider (HCP) for treatment, were enrolled in the study. The required information was collected by interview technique using a predesigned questionnaire.
    UNASSIGNED: A total of 2053 patients were enrolled in the study. There was a significant delay of more than 2 weeks in the diagnosis of pulmonary TB after the onset of symptoms in 94% of patients. The extent of delay ranged from 8 days to 240 days with a mean of 36.33 days. The delay in visiting the HCPs by the patient was not significant. Only 5.85% of patients had a significant delay of more than 2 weeks in seeking any health care after the appearance of symptoms. A delay by HCP contributed to a greater portion of the total delay, with a mean of 31.77 days. The main reason for the delay by HCPs was not investigating TB. The hospital delay was not significant. The mean hospital delay was 5.82 days.
    UNASSIGNED: The delay in the diagnosis of TB in India is very high. A delay by HCPs contributes to a greater portion of the total delay. Information, Education and Communication (IEC) activities will play an important role in reducing the delay. All HCPs should be actively involved in subjecting the suspects to TB diagnosis at the earliest possible as per National Tuberculosis Elimination Programme (NTEP) guidelines.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    分析喀什地区结核病防治“新疆模式”的有效性,新疆,并探讨政策实施效果的决定因素。
    收集了2012-2021年喀什地区肺结核(PTB)患者的登记数据,以描述登记发病率的时间趋势。对2022年1月至2023年7月在泽普县和莎车县结核病管理信息系统中登记和治疗的PTB患者进行问卷调查,以收集和分析“新疆模式”的有效性决定因素。
    2012-2018年喀什地区PTB登记发病率呈显著上升趋势(APC=18.7%),2018-2021年呈显著下降趋势(APC=-28.8%)。在喀什地区,与2012-2017年的平均登记发病率相比,2021年舒福市的登记发病率,Maigaiti,泽普县下降幅度更大,达到58.68%,57.16%,和54.02%,分别,而2021年莎车县的登记发病率增加了6.32%。根据对影响政策实施效果的因素的综合分析,泽普县目前健康状况较治疗前明显改善的肺结核患者比例明显高于莎车县(P<0.05);莎车县患者对如何服用抗结核药物的知晓率明显低于泽普县,预防措施,不良反应,并在治疗期间定期复查;在莎车县和泽普县均占较重治疗负担比例较大的因素是服用或注射药物引起的不适,占12.8%和8.7%,分别。
    "新疆模式"能有效控制喀什地区结核病疫情,以及结核病治疗的知识,结核病药物的不良反应,治疗费用是政策执行效果的决定因素。
    UNASSIGNED: To analyze the effectiveness of the \"Xinjiang Model\" for tuberculosis prevention and control in Kashgar Prefecture, Xinjiang, and to explore the determinants of the policy implementation effect.
    UNASSIGNED: The registration data of pulmonary tuberculosis (PTB) patients in Kashgar Prefecture from 2012 to 2021 were collected to describe the temporal trend of registered incidence. A questionnaire survey was conducted among PTB patients registered and treated in the tuberculosis management information system in Zepu and Shache Counties from January 2022 to July 2023 to collect and analyze \"Xinjiang model\" determinants of effectiveness.
    UNASSIGNED: The PTB registered incidence in Kashgar Prefecture showed a significant increasing trend from 2012 to 2018 (APC=18.7%) and a significant decreasing trend from 2018-2021 (APC=-28.8%). Among the Kashgar Prefecture, compared with average registered incidence in 2012-2017, registered incidence in 2021 in Shufu, Maigaiti, and Zepu Counties had a greater decline rate of 58.68%, 57.16%, and 54.02%, respectively, while the registered incidence in 2021 in Shache County increased by 6.32%. According to the comprehensive analysis of the factors affecting the effect of policy implementation, the proportion of PTB patients in Zepu County whose health status has now significantly improved compared with that before treatment was significantly greater than that in Shache County (P<0.05); patients in Shache County were significantly less aware than those in Zepu County of how to take tuberculosis drugs, precautions, adverse reactions, and regular reviews during treatment; the factors that accounted for the greater proportion of heavy treatment burden in both Shache and Zepu Counties were discomfort caused by taking or injecting drugs, accounting for 12.8% and 8.7%, respectively.
    UNASSIGNED: The \"Xinjiang model\" can effectively control the epidemic situation of tuberculosis in Kashgar, and the knowledge of tuberculosis treatment, adverse reactions to tuberculosis drugs, and treatment costs were the determinants of the effectiveness of policy implementation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    糖尿病(DM)和肺结核(PTB)的共存在全球范围内引起了重大的健康问题,它们的融合给医疗保健系统带来了相当大的挑战。先前的研究强调,合并症可以相互影响并加剧免疫疾病。然而,关于DM对中国结核病人群的免疫学特征和治疗反应的影响的数据很少。
    选择2020年1月至2022年6月在本中心住院的肺结核患者264例(DM患者82例,非DM患者182例)。80例TB合并DM(TB-DM)和80例TB无DM(TB-NDM)患者通过年龄倾向评分匹配纳入最终分析,性别和累及肺野的比例为1:1。临床特点,比较两组患者的免疫学特征和治疗反应。
    倾向得分匹配后,一般特征没有差异,如年龄性别,受累肺野,发现两组之间的再治疗发生率和白细胞计数。与TB-NDM组相比,TB-DM组的痰涂片阳性率和空洞性病变发生率较高.免疫学特征分析显示,TB-DM患者的TNF-α水平[pg/ml;8.56(7.08-13.35)与7.64(6.38-10.14)p=0.033]和IL-8[pg/ml;25.85(11.63-58.40)vs.17.56(6.44-39.08)p=0.003],但较低的CD8+T淋巴细胞计数[细胞/mm3;334.02(249.35-420.71)VS380.95(291.73-471.25)p=0.038]。然而,两组患者血清IL-6浓度和CD4+T淋巴细胞计数差异无统计学意义。抗结核治疗2个月后,39例(24.4%)治疗反应欠佳,包括23例(28.7%)TB-DM患者和16例(20%)TB-NDM患者。两组之间的次优反应率(SRR)没有差异(p=0.269)。多因素logistic回归分析显示结核病复治[AOR:5.68(95CI:2.01-16.08),p=0.001],痰涂片阳性[AOR:8.01(95CI:2.62-24.50),p=0.001]与所有参与者的SRR相关,在TB-DM组中,仅痰涂片阳性[AOR:16.47(1.75-155.12),p=0.014]对SRR呈阳性。
    DM是结核病人群肺腔形成和痰涂片阳性的危险因素。此外,TB-DM患者的特征在于增强的细胞因子应答和减少的CD8+T淋巴细胞。结核病的再治疗和痰涂片阳性与次优治疗反应的发生有关。
    UNASSIGNED: The coexistence of diabetes mellitus (DM) and pulmonary tuberculosis (PTB) poses a significant health concern globally, with their convergence presenting a considerable challenge to healthcare systems. Previous research has highlighted that comorbidities can mutually influence and exacerbate immune disorders. However, there is a paucity of data on the impact of DM on immunological features and treatment responses in the TB population in China.
    UNASSIGNED: From January 2020 to June 2022, 264 cases of pulmonary tuberculosis patients (82 DM patients and 182 non-DM patients) hospitalized in our center were selected. 80 patients with TB with DM (TB-DM) and 80 patients with TB without DM (TB-NDM) were enrolled into the final analysis by propensity score matching for age, gender and involved lung field at a ratio of 1:1. The clinical characteristics, immunological features and treatment response were compared between the two groups.
    UNASSIGNED: After propensity score matching, no differences in the general features such as age gender, involved lung field, the incidence of retreatment and WBC count were found between the two groups. Compared to TB-NDM group, the TB-DM group exhibited a higher positive rate of sputum smear and incidence of cavitary lesions. Immunological features analysis revealed that the TB-DM patients had higher levels of TNF-α [pg/ml; 8.56 (7.08-13.35) vs. 7.64 (6.38-10.14) p = 0.033] and IL-8 [pg/ml; 25.85 (11.63-58.40) vs. 17.56 (6.44-39.08) p = 0.003] but lower CD8+ T lymphocyte count [cells/mm3; 334.02 (249.35-420.71) VS 380.95 (291.73-471.25) p = 0.038]. However, there was no significant difference in serum IL-6 concentration and CD4+ T lymphocyte count between the two groups. After 2 months of anti-tuberculosis treatment, 39 (24.4%) cases had suboptimal treatment response, including 23 (28.7%) TB-DM patients and 16 (20%) TB-NDM patients. There was no difference in suboptimal response rate (SRR) was found between the two groups (p = 0.269). The multivariate logistic regression analysis indicated that retreatment for TB [AOR: 5.68 (95%CI: 2.01-16.08), p = 0.001], sputum smear positivity [AOR: 8.01 (95%CI: 2.62-24.50), p = 0.001] were associated with SRR in all participants, and in TB-DM group, only sputum smear positivity [AOR: 16.47 (1.75-155.12), p = 0.014] was positive with SRR.
    UNASSIGNED: DM is a risk factor for pulmonary cavity formation and sputum smear positivity in TB population. Additionally, TB-DM patients is characterized by enhanced cytokine responses and decreased CD8+ T lymphocytes. The retreatment for TB and sputum smear positivity were associated with the occurrence of suboptimal treatment response.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:确定中性粒细胞淋巴细胞比率(NLR)的关系,单核细胞淋巴细胞比率(MLR),和中性粒细胞单核细胞比率(NMR)与肺结核(PTB)患者在强化期治疗(IPT)期间的治疗反应。
    方法:这项分析性横断面研究是在Ojha胸部疾病研究所(OICD)进行的,陶氏健康科学大学,2021年2月至12月。使用目的抽样技术招募了100名患者。18岁及以上的男性和女性,包括通过耐酸杆菌(AFB)显微镜和基因XpertMTB/RIF对利福平敏感的PTB新诊断病例。SPSS版本26用于分析数据。数值数据以中位数和四分位数范围表示,分类数据以频率和百分比表示。
    结果:在总共100名患者中,81%(n=81)在第2个月后显示AFB痰涂片显微镜(SSM)阴性的治疗反应。81%(n=81)的患者获得治疗反应,83.9%(n=68)的NLR也降低,85.2%(n=69)的MLR降低,83.9%(n=68)的NMR从基线降低。然而,19%(n=19)在ATT(抗结核治疗)第2个月后,AFBSSM阳性未达到治疗反应,其中10.52%(n=2)对INH耐药,第2个月后所有比率均未降低。
    结论:在ATT治疗两个月后,AFBSSM阴性的患者接受PTB治疗后,白细胞比率比基线显着下降,因此这些比率可用作监测治疗反应的标志物。
    OBJECTIVE: To determine the relationship of Neutrophil Lymphocyte Ratio (NLR), Monocyte Lymphocyte Ratio (MLR), and Neutrophil Monocyte Ratio (NMR) with treatment response in Pulmonary Tuberculosis (PTB) patients during intensive phase treatment (IPT).
    METHODS: This analytical cross-sectional study was conducted at Ojha Institute of Chest Diseases (OICD), Dow University of Health Sciences, from February to December 2021. 100 patients were enrolled using purposive sampling technique. Both male and female of age 18 and above, rifampicin sensitive newly diagnosed cases of PTB by Acid Fast Bacilli (AFB) microscopy and Gene Xpert MTB/RIF were included. SPSS version 26 was used to analyze data. Numerical data was expressed in median and interquartile range and categorical data was expressed in frequencies and percentages.
    RESULTS: Out of total 100 patients, 81% (n = 81) showed treatment response with negative AFB Sputum Smear Microscopy (SSM) after 2nd month. Out of 81% (n = 81) of the patients who achieved treatment response, 83.9% (n = 68) also had decreased NLR, 85.2% (n = 69) had decreased MLR and 83.9% (n = 68) had decreased NMR from baseline. However 19% (n = 19) did not achieved treatment response with positive AFB SSM after 2nd month of ATT (Anti tuberculosis treatment), among them 10.52% (n = 2) were INH resistant with no decrease in all the ratios after 2nd month.
    CONCLUSIONS: Leukocyte ratios decreased significantly from baseline as PTB was treated in patients who achieved treatment response with negative AFB SSM after two months of ATT and hence these ratios could be used as markers to monitor the treatment response.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    武汉位于中国腹地,在湖北省东部,在长江和汉水的交汇处。是国家历史文化名城,一个重要的工业,科学,和教育基地,和重要的交通枢纽。武汉有很多学校,有将近一千个各种各样的。学生人数约为220万,占常住人口的近五分之一;大学生约占学生总数的60%。这些学院的地理位置相对集中,人口密度相对较高,使其容易发生结核病集群流行。
    本研究分析了武汉市学校结核病聚集的流行病学特征及影响因素,中国,为2017-2022年学校科学制定结核病防治策略和措施提供依据。
    本研究采用描述性流行病学方法,对2017年1月至2022年12月武汉市学校结核病聚集性流行特征进行分析,采用问卷之星收集全市各类学校结核病防控相关数据,中国网络问卷调查的应用,多因素logistic回归分析结核病聚集性的影响因素。
    从2017年到2022年,武汉市报告了54起学校肺结核聚集性疫情,涉及37所不同的学校,包括32所学院或大学和5所高中;报告了176例病例,其中73例病原体阳性,18例利福平或艾博尼嗪耐药。单个集群流行病的中位持续时间为46(26,368)天。大学比中学更容易发生集群性疫情(χ2=105.160,P=0.001),在聚集性流行病中,男生的发病率高于女生(χ2=12.970,P=0.001)。多因素logistic回归分析结果显示,学校寄宿(OR=7.60)是学校结核病聚集性流行的危险因素。学生人数少(OR=0.50),学校在城市的位置(OR=0.60),对新生进行体检(OR=0.44),进行疾病缺失和原因追踪(OR=0.05),宿舍和教室定期开窗通风(OR=0.16),严格执行病态学生停学管理(OR=0.36),及时就医(OR=0.32)是学校结核病集束化流行的保护因素。
    我们成功识别了武汉市学校结核病聚集的流行病学特征和影响因素。结果揭示了各种因素的影响和现状,为学校在日常活动中改进结核病防治措施指明了途径。这些措施可以有效地遏制学校结核病的聚集性流行。
    UNASSIGNED: Wuhan is located in the hinterland of China, in the east of Hubei Province, at the intersection of the Yangtze River and Hanshui River. It is a national historical and cultural city, an important industrial, scientific, and educational base, and a key transportation hub. There are many schools in Wuhan, with nearly a thousand of all kinds. The number of students is ~2.2 million, accounting for nearly one-fifth of the resident population; college or university students account for ~60% of the total student population. The geographical location of these colleges is relatively concentrated, and the population density is relatively high, making it prone to tuberculosis cluster epidemic.
    UNASSIGNED: This study analyzed the epidemiological characteristics and influencing factors of tuberculosis aggregation in schools in Wuhan, China, during 2017-2022 to provide the basis for the scientific development of tuberculosis prevention and control strategies and measures in schools.
    UNASSIGNED: This study adopted the methods of descriptive epidemiology to analyze the epidemic characteristics of tuberculosis aggregation in schools in Wuhan from January 2017 to December 2022, collecting the relevant data on tuberculosis prevention and control in all kinds of schools in the city using Questionnaire Star, an application of the China network questionnaire survey, and analyze the influencing factors of tuberculosis aggregation by using multifactor logistic regression analysis.
    UNASSIGNED: From 2017 to 2022, 54 outbreaks of pulmonary tuberculosis aggregation in schools were reported in Wuhan, which involved 37 different schools, including 32 colleges or universities and five senior high schools; 176 cases were reported, among which 73 were positive for pathogens and 18 were rifampicin or izoniazid resistant. The median duration of a single cluster epidemic was 46 (26,368) days. Universities were more prone to cluster outbreaks than middle schools (χ2 = 105.160, P = 0.001), and the incidence rate among male students was higher than that of female students in cluster epidemics (χ2 = 12.970, P = 0.001). The multivariate logistic regression analysis results showed that boarding in school (OR = 7.60) is the risk factor for a tuberculosis cluster epidemic in schools. The small number of students (OR = 0.50), the location of the school in the city (OR = 0.60), carry out physical examinations for freshmen (OR = 0.44), carry out illness absence and cause tracking (OR = 0.05), dormitories and classrooms are regularly ventilated with open windows (OR = 0.16), strict implement the management of sick student\'s suspension from school (OR = 0.36), and seeking timely medical consultation (OR = 0.32) were the protective factors for a tuberculosis cluster epidemic in schools.
    UNASSIGNED: We successfully identified the epidemiological characteristics and influencing factors of tuberculosis aggregation in schools in Wuhan. The results revealed the influence and status of various factors and indicated ways for schools to improve their TB prevention and control measures in their daily activities. These measures can effectively help curb the cluster epidemic of tuberculosis in schools.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:在这项前瞻性研究中,通过检查肺结核(PTB)疑似患者的支气管肺泡灌洗液(BALF)样本,确定了基于纳米孔测序的结核分枝杆菌(MTB)检测的诊断准确性.比较了纳米孔测序的诊断性能,分枝杆菌生长指示管(MGIT)培养和XpertMTB/利福平抗性(MTB/RIF)测定。
    方法:对2021年9月至2022年4月在中国各地收集的疑似PTB病例的样本进行测试,然后比较分析诊断准确率。
    结果:在最终诊断为PTB的111例疑似PTB病例中,纳米孔测序的诊断率与其他检测方法差异有统计学意义(P<0.05)。Fleiss\'kappa值为0.219和0.303表明使用纳米孔测序与其他测定获得的MTB检测结果之间的一致性水平相当。分别。MGIT培养的相应PTB诊断灵敏度,XpertMTB/RIF和纳米孔测序的36.11%,40.28%和83.33%表明纳米孔测序的灵敏度较高。曲线下面积(AUC)分析,Youden的指标和准确度值以及阴性预测值(NPV)表明纳米孔测序的MTB检测性能优越(XpertMTB/RIF排名第二),而纳米孔测序的PTB诊断准确率超过了其他方法的相应准确率。
    结论:与MGIT培养和XpertMTB/RIF测定相比,BALF的纳米孔测序提供了优越的MTB检测灵敏度,因此适用于痰液稀缺的可疑PTB病例的检测。然而,在排除PTB诊断之前,应根据其他证据确认使用这些检测方法获得的阴性结果.
    OBJECTIVE: In this prospective study, the diagnosis accuracy of nanopore sequencing-based Mycobacterium tuberculosis (MTB) detection was determined through examining bronchoalveolar lavage fluid (BALF) samples from pulmonary tuberculosis (PTB) -suspected patients. Compared the diagnostic performance of nanopore sequencing, mycobacterial growth indicator tube (MGIT) culture and Xpert MTB/rifampin resistance (MTB/RIF) assays.
    METHODS: Specimens collected from suspected PTB cases across China from September 2021 to April 2022 were tested then assay diagnostic accuracy rates were compared.
    RESULTS: Among the 111 suspected PTB cases that were ultimately diagnosed as PTB, the diagnostic rate of nanopore sequencing was statistically significant different from other assays (P < 0.05). Fleiss\' kappa values of 0.219 and 0.303 indicated fair consistency levels between MTB detection results obtained using nanopore sequencing versus other assays, respectively. Respective PTB diagnostic sensitivity rates of MGIT culture, Xpert MTB/RIF and nanopore sequencing of 36.11%, 40.28% and 83.33% indicated superior sensitivity of nanopore sequencing. Analysis of area under the curve (AUC), Youden\'s index and accuracy values and the negative predictive value (NPV) indicated superior MTB detection performance for nanopore sequencing (with Xpert MTB/RIF ranking second), while the PTB diagnostic accuracy rate of nanopore sequencing exceeded corresponding rates of the other methods.
    CONCLUSIONS: In comparison with MGIT culture and Xpert MTB/RIF assays, BALF\'s nanopore sequencing provided superior MTB detection sensitivity and thus is suitable for testing of sputum-scarce suspected PTB cases. However, negative results obtained using these assays should be confirmed based on additional evidence before ruling out a PTB diagnosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    尽管对肺结核(PTB)与炎症因子之间的关系进行了广泛的研究,更有力的因果证据尚未出现。因此,本研究旨在筛选可能导致不同人群PTB易感性的炎性蛋白,并解释不同种族PTB炎症和免疫机制的多样性.
    采用双样本孟德尔随机化(MR)研究的逆方差加权(IVW)模型对全基因组关联研究(GWAS)的数据进行因果分析。该队列由来自两个欧洲和两个东亚人群的PTBGWAS数据集组成,以及从14,824名参与者中收集的91种人类炎症蛋白。共定位分析旨在确定输入的炎症蛋白和PTB是否在固定区域内共享相同的因果单核苷酸多态性(SNP)变异,从而增强MR分析的鲁棒性。Meta分析用于评估不同数据集之间的联合因果效应。
    在这项研究中,我们观察到肿瘤坏死因子-β水平之间存在显着负相关(我们采用的替代方法是淋巴毒素-α,通常称为LT)(P<0.05)和肿瘤坏死因子受体超家族成员9(TNFRSF9)水平(P<0.05)。这两种炎性蛋白是抗PTB的关键保护因子。此外,白细胞介素-20受体亚基α水平(IL20Ra)之间存在显著正相关(P<0.05),这可能会增加PTB的风险。共定位分析显示,LT和PTBSNP之间的因果变异没有重叠。荟萃分析进一步证实了LT,TNFRSF9和IL20Ra在东亚人群中的表达(P<0.05)。
    特定炎症蛋白的水平可能在触发对PTB的免疫应答中起关键作用。LT和TNFRSF9水平的改变有可能作为PTB发育的预测标志物,需要在现实环境中进行进一步的临床验证,以确定这些炎性蛋白对PTB的影响。
    UNASSIGNED: Despite extensive research on the relationship between pulmonary tuberculosis (PTB) and inflammatory factors, more robust causal evidence has yet to emerge. Therefore, this study aims to screen for inflammatory proteins that may contribute to the susceptibility to PTB in different populations and to explain the diversity of inflammatory and immune mechanisms of PTB in different ethnicity.
    UNASSIGNED: The inverse variance weighted (IVW) model of a two-sample Mendelian Randomization (MR) study was employed to conduct causal analysis on data from a genome-wide association study (GWAS). This cohort consisting PTB GWAS datasets from two European and two East Asian populations, as well as 91 human inflammatory proteins collected from 14,824 participants. Colocalization analysis aimed to determine whether the input inflammatory protein and PTB shared the same causal single nucleotide polymorphisms (SNPs) variation within the fixed region, thereby enhancing the robustness of the MR Analysis. Meta-analyses were utilized to evaluate the combined causal effects among different datasets.
    UNASSIGNED: In this study, we observed a significant negative correlation between tumor necrosis factor-beta levels (The alternative we employ is Lymphotoxin-alpha, commonly referred to as LT) (P < 0.05) and tumor necrosis factor receptor superfamily member 9 levels (TNFRSF9) (P < 0.05). These two inflammatory proteins were crucial protective factors against PTB. Additionally, there was a significant positive correlation found between interleukin-20 receptor subunit alpha levels (IL20Ra) (P < 0.05), which may elevate the risk of PTB. Colocalization analysis revealed that there was no overlap in the causal variation between LT and PTB SNPs. A meta-analysis further confirmed the significant combined effect of LT, TNFRSF9, and IL20Ra in East Asian populations (P < 0.05).
    UNASSIGNED: Levels of specific inflammatory proteins may play a crucial role in triggering an immune response to PTB. Altered levels of LT and TNFRSF9 have the potential to serve as predictive markers for PTB development, necessitating further clinical validation in real-world settings to ascertain the impact of these inflammatory proteins on PTB.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:环丙泊酚是一种有前途的镇静剂。本研究旨在探讨不同性别和年龄的肺结核(PTB)患者复合0.15μg/kg舒芬太尼时,顺丙泊酚抑制纤维支气管镜检查反应的中位有效剂量(ED50)。并评估其有效性和安全性,为临床合理使用顺丙泊酚提供参考。
    方法:选择2023年5月至2023年6月在常州市第三人民医院接受支气管镜检查治疗的PTB患者,采用分层随机方法分为4组。所有患者均静脉注射0.15μg/kg舒芬太尼,然后根据Dixon的上下法注射试验剂量的顺丙泊酚。所有四组的起始剂量为0.4mg/kg,相邻比例为1:1.1。如果同一组中的前一位患者出现阳性反应,例如窒息性咳嗽,则下一位患者接受了10%的顺丙泊酚剂量增加,皱着眉头,以及内窥镜检查期间的身体运动。否则,这被认为是负面反应,下一位患者接受了10%的环丙泊酚剂量减少。从阳性反应到阴性反应的转变被定义为转折点,当出现七个转折点时,该组的研究终止。血流动力学参数,记录各组不同时间点的氧饱和度和不良反应。采用Probit回归分析方法计算四组患者的顺丙泊酚ED50,并进行组间比较。
    结果:四组支气管镜检查用顺丙泊酚复合0.15μg/kg舒芬太尼的ED50为0.465mg/kg,0.433mg/kg,0.420mg/kg和0.396mg/kg,分别。
    结论:在不同性别和年龄的PTB患者中,用于纤维支气管镜检查的顺丙泊酚的ED50不同。
    背景:中国临床试验注册中心,ChiCTR2300071508,于2023年5月17日注册。
    BACKGROUND: Ciprofol is a promising sedative. This study aims to explore the median effective dose (ED50) of ciprofol in inhibiting responses to fiberoptic bronchoscopy in patients with pulmonary tuberculosis (PTB) of different genders and ages when combined with 0.15 μg/kg sufentanil, and to evaluate its efficacy and safety, providing a reference for the rational use of ciprofol in clinical practice.
    METHODS: PTB patients who underwent bronchoscopy examination and treatment at The Third People\'s Hospital of Changzhou between May 2023 and June 2023 were selected and divided into four groups using a stratified random method. All patients received intravenous injection of 0.15 μg/kg sufentanil followed by injection of the test dose of ciprofol according to Dixon\'s up-and-down method. The initial dose of ciprofol in all four groups was 0.4 mg/kg, with an adjacent ratio of 1:1.1. The next patient received a 10% increase in the dose of ciprofol if the previous patient in the same group experienced positive reactions such as choking cough, frowning, and body movements during the endoscopy. Otherwise, it was judged as a negative reaction, and the next patient received a 10% decrease in the dose of ciprofol. The transition from a positive reaction to a negative reaction was defined as a turning point, and the study of the group was terminated when seven turning points occurred. Hemodynamic parameters, oxygen saturation and adverse reactions were recorded at different time points in all groups. The Probit regression analysis method was used to calculate the ED50 of ciprofol in the four groups and compare between the groups.
    RESULTS: The ED50 of ciprofol combined with 0.15 μg/kg sufentanil for bronchoscopy in the four groups were 0.465 mg/kg, 0.433 mg/kg, 0.420 mg/kg and 0.396 mg/kg, respectively.
    CONCLUSIONS: The ED50 of ciprofol used for fiberoptic bronchoscopy varied among PTB patients of different genders and ages.
    BACKGROUND: The Chinese Clinical Trial Registry, ChiCTR2300071508, Registered on 17 May 2023.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号